These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 34394247)
21. Systematic review on the association between ERCC1 rs3212986 and ERCC2 rs13181 polymorphisms and glioma risk. Zhou CX; Zhao JH Genet Mol Res; 2015 Mar; 14(1):2868-75. PubMed ID: 25867436 [TBL] [Abstract][Full Text] [Related]
22. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer. Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265 [TBL] [Abstract][Full Text] [Related]
23. Investigation on the DNA repaired gene polymorphisms and response to chemotherapy and overall survival of osteosarcoma. Ji WP; He NB Int J Clin Exp Pathol; 2015; 8(1):894-9. PubMed ID: 25755792 [TBL] [Abstract][Full Text] [Related]
24. Association of ERCC1 and ERCC2 Gene Polymorphisms with Pancreatic Cancer Risk: A Meta-Analysis. Xie F; Sun Q; Zhang E; Mu Y Crit Rev Eukaryot Gene Expr; 2020; 30(3):231-237. PubMed ID: 32749109 [TBL] [Abstract][Full Text] [Related]
25. Genetic polymorphisms of DNA repair pathways influence the response to chemotherapy and overall survival of gastric cancer. Zhou J; Liu ZY; Li CB; Gao S; Ding LH; Wu XL; Wang ZY Tumour Biol; 2015 Apr; 36(4):3017-23. PubMed ID: 25542228 [TBL] [Abstract][Full Text] [Related]
26. Genotypes and haplotypes of ERCC1 and ERCC2/XPD genes predict levels of benzo[a]pyrene diol epoxide-induced DNA adducts in cultured primary lymphocytes from healthy individuals: a genotype-phenotype correlation analysis. Zhao H; Wang LE; Li D; Chamberlain RM; Sturgis EM; Wei Q Carcinogenesis; 2008 Aug; 29(8):1560-6. PubMed ID: 18635523 [TBL] [Abstract][Full Text] [Related]
27. Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma. Wang MJ; Zhu Y; Guo XJ; Tian ZZ Genet Mol Res; 2015 Sep; 14(3):11652-7. PubMed ID: 26436406 [TBL] [Abstract][Full Text] [Related]
28. ERCC1 and ERCC2 haplotype modulates induced BPDE-DNA adducts in primary cultured lymphocytes. Lu X; Liu Y; Yu T; Xiao S; Bao X; Pan L; Zhu G; Cai Y; Liu Q; Jin C; Yang J; Wu S; An L; van der Straaten T PLoS One; 2013; 8(4):e60006. PubMed ID: 23593158 [TBL] [Abstract][Full Text] [Related]
29. Frequency distribution of DNA repair genes ERCC1 and ERCC2 polymorphisms in South Indian healthy population. Rao KS; SureshKumar S; Umamaheswaran G; Paul A; Dubashi B; Gunaseelan K; Dkhar SA Environ Toxicol Pharmacol; 2014 Sep; 38(2):480-8. PubMed ID: 25155628 [TBL] [Abstract][Full Text] [Related]
30. Genetic variability of DNA repair mechanisms influences chemotherapy outcome of gastric cancer. Yu H; Wu X; Zhang Y; Jin Z; Li G; Zhao H Int J Clin Exp Pathol; 2015; 8(4):4106-12. PubMed ID: 26097599 [TBL] [Abstract][Full Text] [Related]
31. Genetic variability of ERCC1 and ERCC2 genes involved in the nucleotide excision repair pathway influences the treatment outcome of gastric cancer. Zheng DL; Tang GD; Chen YN; Zhang T; Qin MB Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173253 [TBL] [Abstract][Full Text] [Related]
32. Association between ERCC1 and ERCC2 gene polymorphisms and susceptibility to pancreatic cancer. He MG; Zheng K; Tan D; Wang ZX Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27051038 [TBL] [Abstract][Full Text] [Related]
33. Letter regarding Li JS et al. entitled "ERCC polymorphisms and prognosis of patients with osteosarcoma". Jian Y; Tian X; Li B; Zhou Z; Wu X Tumour Biol; 2015 May; 36(5):3195-6. PubMed ID: 25824708 [TBL] [Abstract][Full Text] [Related]
34. Association of ERCC1 C8092A and ERCC2 Lys751Gln polymorphisms with the risk of glioma: a meta-analysis. Xin Y; Hao S; Lu J; Wang Q; Zhang L PLoS One; 2014; 9(4):e95966. PubMed ID: 24763305 [TBL] [Abstract][Full Text] [Related]
35. Association of single nucleotide polymorphisms of DNA repair genes in NER pathway and susceptibility to pancreatic cancer. Zhao F; Shang Y; Zeng C; Gao D; Li K Int J Clin Exp Pathol; 2015; 8(9):11579-86. PubMed ID: 26617894 [TBL] [Abstract][Full Text] [Related]
36. ERCC1 and XPD/ERCC2 polymorphisms' predictive value of oxaliplatin-based chemotherapies in advanced colorectal cancer has an ethnic discrepancy: a meta-analysis. Lu X; Xiao S; Jin C; van der Straaten T; Li X J Clin Lab Anal; 2012 Jan; 26(1):10-5. PubMed ID: 24833529 [TBL] [Abstract][Full Text] [Related]
37. Association between ERCC1 and ERCC2 polymorphisms and breast cancer risk in a Chinese population. Zhao R; Ying MF Genet Mol Res; 2016 Mar; 15(1):15017263. PubMed ID: 26985954 [TBL] [Abstract][Full Text] [Related]
38. DNA Repair Genetics and the Risk of Radiation Pneumonitis in Patients With Lung Cancer: A Systematic Review and Meta-analysis. Yiu WS; Chu TSM; Meng Y; Kong FS Clin Oncol (R Coll Radiol); 2024 Jul; 36(7):e182-e196. PubMed ID: 38653664 [TBL] [Abstract][Full Text] [Related]
39. Role of ERCC2 and ERCC3 gene polymorphisms in the development of osteosarcoma. Ma X; Zhang Y; Sun TS; Yao JH Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27051024 [TBL] [Abstract][Full Text] [Related]
40. Association of genetic polymorphisms in DNA repair genes Alsagaby S; Ahmed AA; Rasheed Z; Althwab SA; Aljohani ASM; Alhumaydhi FA; Alhomaidan HT; Alkhamiss AS; Alkhowailed M; Alaqeel A; Alblihed MA; Alrehaili J; Fernández N; Abdulmonem WA Nucleosides Nucleotides Nucleic Acids; 2022; 41(5-6):530-554. PubMed ID: 35319340 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]